Analyst Consensus
|
FY25 Actual £m |
FY26 Consensus £m |
FY27 Consensus £m |
FY28 Consensus £m |
|
|---|---|---|---|---|
Total Sales |
375.3 |
402.9 |
438.3 |
477.0 |
UK |
108.4 |
108.0 |
108.1 |
108.8 |
US |
131.9 |
152.1 |
178.9 |
207.4 |
Europe |
97.3 |
101.4 |
105.2 |
109.6 |
ROW |
37.7 |
41.6 |
46.1 |
51.3 |
EBITDA |
42.4 |
50.0 |
64.3 |
78.7 |
PBT |
29.9 |
42.6 |
56.2 |
70.2 |
Normalised EPS (p) |
24.12 |
28.68 |
38.82 |
49.17 |
Analyst Consensus
The consensus data was last updated on 17th August 2026.
The Full Year consensus is compiled from 14 analyst submissions and calculated using the simple average of forecasts, estimates and projections provided by investment analysts who cover Fever-Tree. The consensus data is derived from data available through Visible Alpha together with forecasts and estimates obtained directly from covering analysts. The consensus reflects the views of those analysts only and does not represent the Company's own expectations or guidance. Neither the Company nor its management endorses, makes any representation or provides any warranty in relation to the consensus data. While the Company endeavours to ensure the consensus data is accurate and up to date, it is under no obligation to update the consensus data.
Our STRATEGY
Related PAGES
